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Abstract
Background: Many important biological processes are controlled through cell-cell interactions, including the colonization of
metastatic tumor cells and the control of differentiation of stem cells within their niche. Despite the crucial importance of
the cellular environment in regulating cellular signaling, in vitro methods for the study of such interactions are difficult and/
or indirect.
Methodology/Principal Findings: We report on the development of an image-based method for distinguishing two cell
types grown in coculture. Furthermore, cells of one type that are in direct contact with cells of a second type (adjacent cells)
can be analyzed separately from cells that are not within a single well. Changes are evaluated using population statistics,
which are useful in detecting subtle changes across two populations. We have used this system to characterize changes in
the LNCaP prostate carcinoma cell line when grown in contact with human vascular endothelial cells (HUVECs). We find that
the expression and phosphorylation of WWOX is reduced in LNCaP cells when grown in direct contact with HUVECs.
Reduced WWOX signaling has been associated with reduced activation or expression of JNK and p73. We find that p73
levels are also reduced in LNCaP cells grown in contact with HUVECs, but we did not observe such a change in JNK levels.
Conclusions/Significance: We find that the method described is statistically robust and can be adapted to a wide variety of
studies where cell function or signaling are affected by heterotypic cell-cell contact. Ironically, a potential challenge to the
method is its high level of sensitivity is capable of classifying events as statistically significant (due to the high number cells
evaluated individually), when the biological effect may be less clear. The methodology would be best used in conjunction
with additional methods to evaluate the biological role of potentially subtle differences between populations. However,
many important events, such as the establishment of a metastatic tumor, occur through rare but important changes, and
methods such as we describe here can be used to identify and characterize the contribution of the environment to these
changes.
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Introduction
Cancer is a complex disease that is often characterized as
dysregulated growth [1]. While the root of cancer cell proliferation
is the result of a loss of growth and cell cycle regulatory controls
within the cancer cells themselves, changes in the way cancer cells
interact with the surrounding environment are also critical to
tumor development and clinical cancer [2,3]. These include
proliferative and invasive signals transmitted from stromal cells
and proangiogenic signals from cancer cells to the endothelium.
These interactions between cancer cells and their environment
have been more difficult to characterize and target for therapeutic
intervention than intrinsic changes to cancer cells, since in vitro
models of cell-cell interactions are difficult to establish and
standardize, especially at the scale necessary for drug screening.
Despite these difficulties, the interaction between cancer cells and
their environment have proven to be an effective strategy for
treating cancer [4], and therefore increased attention to how
cancer cells function as tumors is an important problem.
Methods for the in vitro study of cancer cell interactions with
stromal and endothelial cells have been developed, such as how
cancer cells induce angiogenesis and recruit macrophages [5–8].
Related methods allow the study of intercellular signaling through a
coculture phase for inducing paracrine and heterotypic contact-
dependent changes, followed by separation of the cell types for
quantitation by transcriptional profiling, western blotting or related
methods. The ability to detect changes in samples grown in direct
coculture, mixed monoculture (through the use of inserts or related
physical barriers), and standard monoculture using conditioned
media allow such processes to be attributed to specific levels of
interactions. Whilevaluable, these systems carry limitations by relying
on responses that must be averaged across the entire sample for each
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cell types after direct coculture to generate homogenous samples for
profiling or related analyses. The integration of quantitative
fluorescence microscopy (High Content Screening, or HCS) into
the early drug discovery process and basic biological research [9–11]
offers methods for improving coculture studies by facilitating the
direct measurement of morphology, proliferation and cellular
signaling in cells grown in direct contact with different cell types.
We have developed and tested an algorithm for quantifying
changes in epithelial cancer cells grown in direct contact with
endothelial cells. The method identifies cell type and location to
determine the proximity of endothelial cells to cancer cells, and
quantitates cellular features, including cell health and the extent of
activationofsignaling pathwaysforcellsadjacentto endothelialcells
and compares these features to epithelial cells that are non-adjacent
to endothelial cells. The process can be reversed, to characterize
changes in endothelial cells that result from interactions with cancer
cells. The effect of cancer cells on endothelial cells can be measured
by comparing these two groups within the same sample without
separating cells. We demonstrate the approach using prostate and
breast cancer cells, and validate the method by demonstrating that
gene expression changes identified in transcriptional profiling
studies are observed in samples studied with the methods described.
Materials and Methods
Cells, media, reagents and culture conditions
HUVEC cells were purchased from Cambrex (Cat#: CC-2519)
and maintained in EBM-2 medium (Endothelial Cell Growth
Medium: CC-3162 with 2%FBS), HUVEC cells were cultured for
no more than ten passages. The prostate cancer line LNCaP
(ATCC, Manassas, VA) was grown in RPMI1640 supplemented
with glutamate, non-essential amino acids, penicillin-streptomycin
and 10% FBS (all from Invitrogen, Carlsbad, CA).
Mouse anti-CD31 (Cat#: 550389) was from BD Pharmingen
(San Diego, CA), Mouse anti-CDw75 (IgM) (Cat #: ab9515-500)
was from Abcam (Cambridge, MA), Rabbit anti WWOX (28–42)
(Cat #: AP1008) was from Calbiochem/EMD Chemicals (Gibbs-
town, NJ), Rabbit anti-(pThr33)WWOX (Cat #: AP1009), was
from Calbiochem/EMD Chemicals, mouse anti p73 (Cat #: 32-
4200) was from ZyMed/Invitrogen, mouse anti-c-Jun (Cat #:
OP55) was from Calbiochem, mouse anti-JNK1 (Cat #:
MAB17761) was from R&D Systems (Minneapolis, MN).
High content analysis
HUVEC and LNCaP cells were cultured separately in T75
flasks, trypsinized and mixed in a 1:1 ratio in EBM2-2%FBS
medium, at 5000 cells (total)/well into Poly-D-lysine-coated 96-
well plates(BD: Biocoat 356640). 48 hr later, cells were washed
once in PBS, fixed in 4% PFA for 10 min, washed twice with PBS,
permeabilized by incubating in 1% Triton-X 100 for 3 min, and
washed three times in PBS. All antibody staining were performed
in PBS with 1% goat serum. The primary antibodies were added
at their empirically-determined optimal dilution: anti-CDw75 at
1:50; anti-WWOX, anti-pWWOX, anti-P73, anti-c-Jun, anti-
JNK1 were all used at a dilution of 1:100. After three PBS washes,
Alexa-labeled secondary antibodies (Molecular Probes/Invitrogen)
were added at a 1:200 dilution and DAPI was added to stain
nuclei, as indicated in the figure legends.
Coculture, separation and RNA preparation for
Transcription Profiling
LNCaP and HUVEC cells were expanded separately in T75
flasks. HUVECs were grown to 70% confluence, at which point
7610
5 LNCaP cells were seeded, and cells were grown
in EBM2-2% FBS for 48 hr. Cells were trypsinized and
resuspended in 1 ml (for one T75 flask) ice-cold PBS/
0.1%BSA(,4610
6 cells/ml), 25 ml CD31-bound Dynabeads
(4610
8 beads/ml) (Invitrogen:111-55D) were added, mixed
well and incubated at +4C with gentle tilting and rotation for
20 min. 1 ml ice-cold PBS/0.1%BSA was added and the sample
was placed on a Dynal MPC (Magnetic Particle Concentrator,
Invitrogen) for 2 min to sediment the beads. The supernatant,
which contained the LNCaP cells, were saved separately, and
the beads were resuspended in 1 ml ice-cold PBS/% 0.1BSA
again, and the supernatant was removed and saved. The wash
process was repeated 4 times and the supernatants pooled. The
pool was spun down and the pellet was labeled the LNCaP
fraction and the beads were labeled as the HUVEC fraction.
RNA lysis buffer was added into both fractions and RNA was
purified using a Qiagen miniRNA kit (Valencia, CA). mRNA
samples were prepared and processed for transcriptional
profiling using the Affymetrix U133A GeneChips as described
previously [12].
Proximity algorithm
Cell cocultures are stained with DAPI, which will stain the
nuclei of all cells, and a second cell type specific stain. We are
using either CD44 to identify HUVEC cells or CDw75 to identify
LNCaP cells. Fluorescence is quantified using a Cellomics VTi
high content scanner. Images were analyzed in CellProfiler [13]
provided the x-y coordinate location of a nucleus within a given
image. Using the nuclear x-y coordinates, the x and y offsets of one
cell from another cell can be calculated. These offsets provide the
length of the sides of a right triangle.
The distance d between the two nuclei is calculated using these







and Dx is the x distance between x1 and x2 and Dy is the y distance
between y1 and y2. If the distance d is less than the average
diameter of the cells, the two cells are considered to be adjacent to
each other. In contrast, if the distance d is greater than the average
diameter of the cells, the two cells are considered to be non-
adjacent. The average diameter of the cells was determined by
tabulating the ‘‘MajorAxisLength’’ and ‘‘MinorAxisLength’’
values that were calculated by CellProfiler for a set of reference
images.
The nuclear distance, and the CDw75 staining or CD44
staining were then used to determine which HUVEC cells were
in contact with an LNCaP cell through the following process.
The first step includes identifying all cells in the overall
coculture population using the nuclear stain DAPI. The second
step is to subdivide the population of all cells into two
subpopulations, those cells that stain with CD44 (HUVEC)
and those that stain with CDw75 (LNCaP). Finally, the third
step is to further subdivide the epithelial population into two
subpopulations, those LNCaP cells adjacent to a HUVEC cell
and those non-adjacent to a HUVEC cell. A list of all LNCaP
cells (CDw75 positive or CD44 negative) and HUVEC cells
(CDw75 negative or CD44 positive) was constructed. The
Pythagorean distance for each LNCaP cell compared to each
HUVEC cell was calculated. The distances smaller than the
average diameter of an LNCaP cell were flagged as LNCaP cells
adjacent to HUVEC cells.
Imaging Cell-Cell Signaling
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Adjacent and non-adjacent subpopulations of cells were
identified using the previously described proximity algorithm.
The intensity of an antigen of interest was compared across these
two populations using the ks.test function in the R programming
language (www.r-project.org). A two-sided ks.test p-value of less
than 0.05 was used to infer that the two subpopulation
distributions did not come from the same parent distribution.
Mosaic analysis of adjacent and non-adjacent LNCaP cells
For the data shown in the figure, two wells were considered.
From these two wells, 3428 LNCaP cells were available, and
categorized as either adjacent (655) or non-adjacent (2773). From
these cells, all possible 655 adjacent cells were selected, and 1000
non-adjacent cells were randomly sampled. To make a square
mosaic, the first 625 cells from each of these samples were
displayed in a 25625 matrix of images. Each cell image was a
10610 pixel square, centered on the (x,y) coordinates of a cell.
Channel 3 images (p73) were displayed using the default hsv color
map, with fixed 12-bit color limits (intensities from 0–4096) so that
intensity scales were the same for all images.
Results
Development of an image-based method for the study of
endothelial cells in direct contact with cancer cells
Through indirect immunofluorescence of cell type-specific
antigens, we have been able to identify conditions that allow the
cells of different origins to be labeled for HCS. Conditions for
specifically labeling HUVEC cells have already been described,
through the use of antibodies specific for PECAM, or CD31 [14].
Such labeling is used for flow cytometry-based studies and as such
there was a high likelihood that such detection would be possible
in an adherent culture system. Antibodies were obtained from
commercial sources and with minimal screening fixation and
staining conditions were determined. A wide variety of candidate
markers are available for the detection of prostate carcinoma cells,
most notably prostate-specific antigen (PSA) and prostate-specific
membrane antigen, which are both clinically relevant to prostate
cancer (although PSA itself is a secreted protein, its production can
be detected within prostate cancer cells) [15]. Additional candidate
markers include tumor antigens that normally show highly
restricted expression (typically to fetal or limited adult tissue
types). One example from this latter category is CDw75, a cell-
surface marker for B cell lymphocytes produced by a beta-
galactoside alpha-2,6-sialyl-transferase [16]. Expression of CDw75
antigens have been observed in many epithelial cancers, such as
the stomach, and colon [17,18]. In a screen of candidate markers
for the detection of prostate carcinoma cells in coculture with
endothelial cells, we found that CDw75 was a specific marker for
all three prostate cell lines under study. Coculture experiments
showed that the cell types could be readily and definitively
identified using antibodies to these markers.
Following the identification of specific cell types in coculture, we
sought to identify cells that are in heterotypic contact. Our
approach to doing this was to identify all cells by type and location,
and then develop a method for parsing cells in groups of adjacent
and non-adjacent cells with respect the cells there target
population is in coculture with. HCS is highly multiparametric,
capturing between a dozen and more than 100 features per cell
[10,11,19]. Fundamental features include DNA content, size and
shape of the nucleus. Additional features are dependent on the
methods used to label the cells, and can include measurements of
the cytoskeleton, organelles, or specific proteins and their
Figure 1. Identification of adjacent and non-adjacent endo-
thelial cells in culture with prostate carcinoma cells. Coculture of
LNCaP cells and HUVECs, LNCaP cells are labeled with anti-CDw75
antibodies and shown in red, HUVECs are labeled with anti-CD44
antibodies, in green. A. An example field image. B. Quantitation of
CDw75 fluorescence used in characterizing cells as either LNCaP (high
intensity, red) or HUVEC (low intensity, green). C. Mapping LNCaP cells
and HUVECs. Locations can be compared to cells in panel A. Cells are
identified as adjacent LNCaP in yellow, non-adjacent LNCaP cells in red
and HUVECs in green.
doi:10.1371/journal.pone.0006822.g001
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the current study, we have developed conditions for detecting
individual cells and their expression of either CD31 or CDw75
antigens, and their location in the field. The last feature allows us
to determine the proximity of two cells to each other. The
identification of a cell as adjacent can be strictly defined by the
distance of the nuclei of a cancer cell to an endothelial cell. As
such, cells can be segregated into adjacent and non-adjacent, and
differences between these two groups can be determined.
The algorithm has been used to identify adjacent and non-
adjacent LNCaP cells, relative to HUVEC cells, as shown in
Figure 1.I nFigure 1A, LNCaP cells, labeled with an anti-
CDw75 antibody in red, are seeded with HUVECs, stained with
an anti-CD44 antibody in green. The intensity of the CDw75-
based fluorescence is recorded for each cell in the field. Each cell is
numbered, and the intensity for each cell is shown in Figure 1B.
From this measurement, cells can be categorized as either cancer
or endothelial cells. In addition to the CDw75 staining, other
properties associated with cancer cells can be used at this stage,
including DNA content (many cancer cell lines, including LNCaP
are aneuploid and have significantly higher DNA content than
primary cells). These data can be included with the antigen
intensity to score cells as cancerous or not, or in some cases can be
used as a single parameter for this determination (data not shown).
Once the cells have been identified, their spatial information is
used to map each cell to its location. Having identified each cell as
LNCaP or HUVEC, each cell is then scored for the cells that are
near it, the boundary distance being set by the average diameter of
the cells. Cells of one type, LNCaP in this example, are therefore
further defined as adjacent to HUVEC or not. Cells identified as
adjacent are shown schematically in Figure 1C in yellow, or non-
adjacent, in red. HUVEC cells are shown as green. From this
point forward, quantitative data may be extracted and analyzed
for the two subsets of LNCaP cells. Differences between these
subsets are indicative of a response to direct contact with HUVEC
cells.
A major challenge to developing a proximity algorithm for
HUVECs can be seen in Figure 1C. The heterogeneity in both
size and shape of the cells makes it difficult to assign a distance
between two cells based on the location of the nucleus. Assigning a
distance from a nucleus that represents an average radius for the
cell body misrepresents the interactions between many cells. Cells
that vary in size, or are significantly elongated, cannot be
addressed in most current image analysis algorithms. Two
practical questions are (a) what steps can be instituted to minimize
the effects of variability in cell size, and (b) how much error can the
algorithm tolerate before an effect can not be observed? The
effects of changing the way in which cells are plated was examined
next, the overall impact of the variability of coculture plating
conditions on the robustness of the approach in general was
evaluated in the analysis section, later in this study.
Candidate genes in endothelial cells that show changes
in expression levels when cultured with cancer cells
Several studies have been published that describe changes in
gene expression levels in cancer cell lines grown in coculture [21–
25]. Each system has identified specific signaling pathway events,
in both cancer and stromal cells, that are triggered by cell-cell
contact. We sought to identify changes in the cell lines we are
using in these studies as the most robust source of candidate
proteins to be used to validate the system we have described. We
used seeded LNCaP prostate carcinoma cells and HUVEC
endothelial cells as the coculture system to develop a list of
candidate genes for validation studies. This was accomplished
using traditional methods for direct coculture, the growth of cells
for a specific period of time, followed by a mechanical separation
of the two cell types. Specifically, we used CD31-conjugated beads
to rapidly and quantitatively separate the endothelial cells from the
prostate carcinoma cells, following trypsinization of the mixed
culture. The ability of the beads to separate the two cell types was
characterized by immunofluorescence and by RT-PCR. The two
samples of cells were checked by indirect immunofluorescence
using CD31 antibodies, and it was shown that the cells separated
by the beads were indeed CD31 positive, whereas the cells not
bound by the beads were CD31 negative. These results indicated
that the method was able to quantitatively separate the two cell
types following coculture.
Transcriptional changes that occur in LNCaP cells after coculture
with HUVEC cells were identified using oligonucleotide arrays,
comparing growth of the cells in coculture with HUVEC cells and
after growth as a mock coculture; monoculture cells were treated with
the bead-based separation protocol in a manner identical to the actual
coculture samples. Prior to full transcriptional profiling by oligonu-
cleotide microarrays, we checked the separation of the cell types by
RT-PCR of three genes expressed in endothelial cells. The data are
presented in Figure 2. Here, results for three genes are shown for the
Figure 2. Separation of endothelial and prostate carcinoma cells after coculture. RT-PCR analysis of entothelial genes in samples of mono
and coculture following a separation of the cell types. Cells grown as monocultures, either endothelial or prostate cells, were treated in a manner
identical to that used to separate cells after coculture. Cells recovered by binding to ant-CD31-conjugated beads and pelleted. Expression data for
each gene/condition is reported as its expression level relative to the control gene (b-2-macroglobulin) for each sample. Circles: pellet; Triangles:
supernatant [depending on the Journal, they may want this info in a legend; The original figure has a legend]
doi:10.1371/journal.pone.0006822.g002
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Gene Symbol Gene Name Fold Change p-Value
MYL9 myosin, light polypeptide 9, regulatory 4.68 4.84E-02
GLRX glutaredoxin (thioltransferase) 4.07 4.94E-02
STK17A serine/threonine kinase 17a (apoptosis-inducing) 4 5.02E-03
IL6ST interleukin 6 signal transducer (gp130, oncostatin M receptor) 3.77 3.75E-02
MBNL2 muscleblind-like 2 (Drosophila) 3.61 1.14E-02
MGC14376 hypothetical protein MGC14376 3.59 2.92E-02
FLJ35155 hypothetical protein FLJ35155 3.56 9.32E-03
IFITM3 interferon induced transmembrane protein 3 (1-8U) 3.55 4.65E-02
OPTN optineurin 3.25 4.00E-02
SOD2 superoxide dismutase 2, mitochondrial 3.22 4.08E-02
HES1 hairy and enhancer of split 1, (Drosophila) 3.22 4.42E-02
PTPRK protein tyrosine phosphatase, receptor type, K 3.06 2.77E-02
CORO1C coronin, actin binding protein, 1C 2.86 4.12E-02
ITGB5 integrin, beta 5 2.77 4.25E-02
MAN2A1 mannosidase, alpha, class 2A, member 1 2.63 3.35E-02
AOF2 amine oxidase (flavin containing) domain 2 2.61 4.90E-02
na CDNA FLJ42565 fis, clone BRACE3007472 2.56 8.37E-03
TNFRSF21 tumor necrosis factor receptor superfamily, member 21 2.56 1.46E-02
INHBC inhibin, beta C 2.56 2.16E-02
MGLL monoglyceride lipase 2.52 6.08E-03
SASH1 SAM and SH3 domain containing 1 2.51 1.31E-02
MOBK1B MOB1, Mps One Binder kinase activator-like 1B (yeast) 2.48 4.82E-02
KPNA3 karyopherin alpha 3 (importin alpha 4) 2.47 3.49E-02
RALB v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) 2.44 4.80E-02
CDNA: FLJ21778 fis, clone HEP00201 2.43 1.83E-02
APP amyloid beta (A4) precursor protein (protease nexin-II, Alzheimer disease) 2.42 2.85E-02
(PYGO2, SHC1) (SHC (Src homology 2 domain containing) transforming protein 1, pygopus 2) 2.4 2.85E-02
WIPI49 WD40 repeat protein Interacting with phosphoInositides of 49kDa 2.37 2.31E-02
USP48 ubiquitin specific protease 48 2.35 2.01E-03
TANK TRAF family member-associated NFKB activator 2.33 1.53E-02
RAP2B RAP2B, member of RAS oncogene family 2.33 3.92E-02
WDR1 WD repeat domain 1 2.32 3.45E-02
RAB3B RAB3B, member RAS oncogene family 2.31 1.87E-02
DRCTNNB1A 2.31 2.74E-02
EHD4 EH-domain containing 4 2.29 2.64E-02
MOBK1B MOB1, Mps One Binder kinase activator-like 1B (yeast) 2.27 2.73E-03
TAGLN2 transgelin 2 2.26 3.67E-02
TJP2 tight junction protein 2 (zona occludens 2) 2.24 4.54E-02
LRRC8 leucine rich repeat containing 8 2.22 1.40E-02
GPSM3 G-protein signalling modulator 3 (AGS3-like, C. elegans) 2.15 4.52E-02
FLJ39370 hypothetical protein FLJ39370 2.12 3.11E-02
ADSS adenylosuccinate synthase 2.11 2.37E-02
ADAM19 a disintegrin and metalloproteinase domain 19 (meltrin beta) 2.07 3.96E-02
TGOLN2 trans-golgi network protein 2 2.02 4.67E-02
VMP1 likely ortholog of rat vacuole membrane protein 1 2 1.50E-02
WWOX WW domain containing oxidoreductase 22.02 3.61E-02
ZC3HDC6 zinc finger CCCH type domain containing 6 22.37 4.65E-02
CDNA FLJ40165 fis, clone TESTI2015962 27.04 1.80E-02
TNRC9 trinucleotide repeat containing 9 27.72 4.41E-02
TNFRSF19 tumor necrosis factor receptor superfamily, member 19 213.24 1.88E-02
doi:10.1371/journal.pone.0006822.t001
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KDR/MET and VE Cadherin are expressed well in HUVEC cells,
but poorly in LNCaP cells, as shown in the monoculture (mock)
experiments in Figure 2. Data from the coculture samples shows the
eliminationof HUVEC cellsfromthe LNCaPcells in the supernatants
to be essentially complete. Therefore, we have been able to culture
LNCaP cells with HUVEC cells, and then separate the cell types for
transcriptional profiling analysis.
Transcriptional profiling identified 44 genes that were upregu-
lated by coculture with HUVEC cells, and 4 genes that were
downregulated, shown in Table 1. Four genes were identified by
two qualifiers each on the oligonucleotide arrays, MOBK1B,
SASH1, TGOLN2 and WIPI49; redundant qualifiers were
removed from the list. From the candidate genes on this list, we
screened commercial suppliers for antibodies that would specifi-
cally identify the targets by Western blotting and indirect
immunofluorescence. In many cases, commercial antibodies were
not sufficiently specific, as determined by both Western blotting
and HCS. Generally, the antibodies either gave a significant cross-
reacting band in Western blots or did not show a titratable staining
in a cellular pattern expected for the antigen. This was the case for
TNFRSF19, which had the most dramatic change in mRNA
expression levels. However, in the case of WWOX, identified as
down-regulated by cell-cell contact in LnCaP cells, we were able to
identify and validate appropriate reagents. WWOX has been well-
characterized as a tumor suppressor, following studies that its
expression is frequently lost as a result of translocations within the
fragile site FRA16D [26,27], including prostate cancers [28].
Although expression is lost in many cancers, its expression can
frequently be observed in many cancer cell lines [29]. WWOX is
phosphorylated at the Thr-33 residue in response to treatment
with TNF-a and hyaluranidase [30]. Phosphorylated WWOX will
then activate p53, but this induction of apoptosis is suppressed by
JNK1, in part through a direct association with WWOX [31]. As
such, reduced WWOX expression would also attenuate apoptosis
resulting from exposure to foreign environments, such as pre-
metastatic sites prior to the establishment of new tumor growth.
The identification of significantly reduced expression of WWOX
in LNCaP cells by contact with HUVECs presents a biologically-
relevant process that could be analyzed in the system we describe.
Detection of changes in signal transduction pathways in
prostate carcinoma cells resulting from cell-cell contact
To test the response of WWOX levels to coculture, the
methodology needed to be altered. Specifically, the method is
currently not robust in four channels, due to spectral overlap in the
blue to orange range of the spectra and some weakness in the
intensity in the red range. As such, labeling of one antigen needed
to be omitted to include WWOX. We tried omitting the CD31
antigen and testing whether CDw75 staining was sufficient to
differentiate between LNCaP cells and HUVECs. Monocultures
and cocultures were evaluated to determine the distribution of
CDw75 staining levels in each cell type and to determine the point
at which HUVECs began to be called as LNCaPs. The range of
Figure 3. Identification of WWOX levels in prostate carcinoma cells. LNCaP cells and HUVECs in coculture were labeled using (panel A) DAPI,
to identify nuclei, (panel B) anti-CDw75 antibodies, to identify LNCaP cells, and (panel C) anti-WWOX antibodies. In panel D, cells classified as HUVEC
are shown as red squares, adjacent LNCaP cells as yellow squares and non-adjacent LNCaP cells as blue squares.
doi:10.1371/journal.pone.0006822.g003
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initial phase of the study (Figure 1), where LNCaP cells showed a
broad range of staining, but only a few cells per field were stained
lightly enough that they could be classified as HUVECs, and
therefore this method of distinguishing the two cell types appeared
robust enough to allow for staining of WWOX or phospho-
WWOX as well. The identification of cell types and quantitation
of WWOX levels are shown in Figure 3. Association of the
signaling intensities with the correct cell type was improved over
initial studies (described above) by limiting the number of cells
plated, particularly for the HUVECs.
To test the image-based approach we have developed, we
examined whether the changes in WWOX expression we
identified in the transcriptional profiling studies could be
recapitulated in LNCaP cells in the system we have described
above. WWOX protein levels in LNCaP cells in adjacent and non-
adjacent cells were compared. Multiple wells were used to culture
LNCaP cells and HUVECs and were subsequently fixed and
stained with DAPI and antibodies to CDw75 and either WWOX
or phospho-WWOX. LNCaP cells were determined to be either
adjacent or non-adjacent to HUVECs and analyzed for target
protein levels. Average target protein levels and standard
deviations were determined. From these data, the ratio and p-
value of target protein levels in adjacent and non-adjacent LNCaP
cells were calculated. Data from these comparisons are presented
in Figure 4. The data shows that adjacent LNCaP cells frequently
have reduced levels of both WWOX and phospho-WWOX and as
the difference becomes larger, the greater the significance of the
measurement. Conversely, wells not showing a difference were not
as statistically robust. This seems to show that it is not always
possible to make a determination about whether direct contact has
had an effect, but when we can make a determination, the results
show that these antigens are lower in the LNCaP cells that contact
HUVEC. Wells that fail to show an effect have been compared to
those that do, and we observe that wells that fail to show a
difference do so as a result of too few LNCaP cells being scored as
adjacent, typically through an uneven distribution of cells during
plating.
A separate observation is that although the differences in many
wells are statistically significant (with p values below 1610
23), the
magnitude of the effect appears modest. At this stage we
considered a different numerical test of the difference between
target protein levels in LNCaP populations. The test we used was
the Kolmogorov-Smirnov (or KS) statistic. The test compares two
populations as fractional contributions to the total amount of
antigen. Results for WWOX levels are shown in Figure 5A and
for phosphorylated WWOX, which is mediated by Src, as shown
in Figure 5B. The difference in the two curves shows that LNCaP
cells adjacent to HUVECs have less WWOX protein than LNCaP
cells that are non-adjacent to HUVECs when compared in a
ranked listing.
Phosphorylation of WWOX by Src results in binding to JNK1,
p53 and p73 [31-33], and these associations have been associated
with reduced apoptosis. Reducing apoptosis is an essential step in
tumorigenesis [2], and would be expected for cancer cells
encountering non-native cell types during invasion and metastasis,
and in fact this is linked directly to JNK1 function [34]. Since
WWOX and pWWOX levels are reduced in adjacent LNCaP
cells, we decided to examine the levels of c-Jun, JNK1 and p73 as
well. Results for these proteins are shown in Table 2. The three
proteins show varying extents of sensitivity to the proximity of
HUVECs. c-Jun and JNK1 exhibit only modest effects as shown
Figure 5. Quantitation of WWOX and phospho-WWOX levels in
LNCaP cells. The amount of WWOX protein (in panel A) and phospho-
WWOX protein (in panel B), are shown for LNCaP cells adjacent to
HUVECs (in red) and those cells non-adjacent to HUVECs (in black). Data
points represent (phospho-) protein levels per cell as a they contribute
to the total antigen intensity for the entire field.
doi:10.1371/journal.pone.0006822.g005
Figure 4. Effect of direct contact with HUVEC cells on the
expression and phosphorylation of WWOX in LNCaP cells.
Independent determinations, over multiple wells, of the ratio of WWOX
(black squares) and phospho-WWOX (red squares) levels in LNCaP cells
that are adjacent or non-adjacent to HUVECs are shown. Each point
represents an individual well, where ,350 adjacent and ,1500 non-
adjacent LNCaP cells were evaluated.
doi:10.1371/journal.pone.0006822.g004
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stronger effect, comparable to what was observed for WWOX and
phospho-WWOX in the previous assays. This last result is
consistent with findings by others, and the analysis of c-Jun and
JNK1 do not refute the published studies, again suggesting that
this approach is not always capable of making a determination
regarding the effect of cell-cell contact, but when a determination
can be made, it has supported a model of contact reducing
expression and signaling of WWOX in LNCaP cells.
The data from these experiments were also evaluated at the
population level through the KS statistic. The results for c-Jun
shows that the small difference observed in the adjacent/non-
adjacent ratio in Table 2 (0.9952) are reflected in Figure 6A as
highly coincident curves. While some of tests of coculture on c-Jun
levels appear to show a difference (ratios,0.95 and a p value of
0.482), the effect is difficult to establish through multiple testing. In
the case of p73, shown in Figure 6B, the difference of 0.9155 (p
value,1610
23) in the overall ratio is seen in the separation of the
distribution curves. While subtle, the difference is reflected in the
entire population rather than a specific subset of cells, such as a
group of apoptotic cells that are specific to the adjacent cells.
Statistical summaries for the comparisons in Figure 5 and
Figure 6 are shown in Table 3.
As noted previously, one of the major challenges to this
approach is the subtly of the measurements. Specifically, changes
in two groups of cells are detected using population-based
methods, such as the KS statistic, and need to be reconciled with
direct observation wherever possible. This is difficult to achieve by
examining single fields of cells, where the variability in each
sample group can make group-wide trends difficult to detect. To
address this, we have grouped images of cells into mosaics, which
provide a stronger visual effect based on larger groups of cells
within each class. The results for the p73 in adjacent and non-
adjacent LNCaP cells are shown in Figure 7. The mosaics
support the analytical methods identification of p73 levels being
lower inLNCaP cells that contact HUVECs.
Discussion
The interactions between different cell types have long been
recognized as important to basic biology and therapeutic function,
but methods for their study have been difficult to establish. in vitro
biology requires reproducibility and quantitation, and drug
discovery requires these factors to a greater extent. The
heterogeneity of primary cells in culture, and of the responses
observed in complex systems in general, have been barriers to their
study. This is changing with the advent of quantitative microscopy
and informatic approaches to large datasets [35,36]. These studies
have established the use of morphological and multiparametric
methods for the study of genetic and chemical perturbations on
cells in coculture.
The data described here presents a general method for
measuring changes in cultured cells grown in direct contact with
cells of another type. The methodology has been validated using
HUVEC and human cancer cell lines, but could be readily
extended to any two cell types that can be distinguished
morphologically or immunofluorescently, including macrophages,
pericytes, adipocytes, neurons or stem cells.
The method is quite flexible. This methodology can be applied
to tissue samples [37], enabling comparisons between in vitro and in
vivo samples for a given cell type and treatment. We have also been
able to classify cancer and normal cells solely on DAPI staining
intensity. Many cancer cell types are aneuploid. Depending on the
extent of aneuploidy, cancer cells can be distinguished from
diploid endothelial by their increased DNA content and staining
with DAPI. A direct comparison of the staining intensity of cancer
and endothelial cell nuclei can identify a staining threshold that
can be used to sort a coculture into its two constitutive cell types.
Table 2. Ratios of c-Jun, JNK1, and p73 in adjacent and non-adjacent LNCaP cells.
Protein mean.lncap sd.lncap mean.adjlncap sd.adjlncap p-value* ratio
c-Jun 0.0627 0.0159 0.0624 0.0205 0.4821 0.9952
0.0636 0.0179 0.0621 0.0144 0.3239 0.9764
0.0635 0.0213 0.0607 0.0146 0.0108 0.9559
0.0622 0.0212 0.0594 0.0113 0.006 0.955
0.0637 0.0161 0.0601 0.0131 6.00E-04 0.9435
0.0694 0.0207 0.0647 0.0162 5.00E-04 0.9323
JNK1 0.0923 0.0233 0.0892 0.0222 0.033 0.9664
0.0918 0.0242 0.0871 0.0238 0 0.9488
0.0984 0.0285 0.0929 0.0252 2.00E-04 0.9441
0.1004 0.0308 0.0936 0.0236 6.00E-04 0.9323
0.091 0.022 0.0848 0.0186 0 0.9319
0.0936 0.0353 0.087 0.0215 0 0.9295
p73 0.144 0.0439 0.1339 0.0459 0 0.9299
0.1696 0.0689 0.1632 0.0806 0.0069 0.9623
0.1432 0.0428 0.1311 0.0437 0 0.9155
0.1387 0.0438 0.1206 0.0431 0 0.8695
0.1824 0.0843 0.157 0.064 0 0.8607
0.1851 0.0866 0.1579 0.0599 0 0.8531
Data are for each protein as determined by six independent wells each.
*p-value from T-test comparison of adjacent and non-adjacent LNCaP cells.
doi:10.1371/journal.pone.0006822.t002
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subdivision of the endothelial population into adjacent and non-
adjacent cells proceeds as described previously.
The advantages of this method over others, such as transcrip-
tional profiling, are (a) significantly fewer manipulations are
needed to prepare samples between culturing and fixation or
lysing, which can affect some of the responses to a perturbation, (b)
effects from direct cell-cell contact can be distinguished from
secretion-mediated signaling, and (c), single cell events are
recorded, allowing for powerful statistical tests to used in
evaluating samples. This is not to say that other methods are
incapable of detecting important signaling events between cells.
Indeed, we have combined transcriptional profiling and HCS to
characterize the effect of cell-cell contact on WWOX-JNK
signaling.
The utility of methods for the study of signaling events mediated
by cell-cell contact is becoming better appreciated. Probably the
best recognized area of research that takes tissue organization and
cell-cell contact into consideration is stem cell biology. The growth
and differentiation of stem cells is explicitly controlled by their
interactions with other cell types within the niche, and exclusion of
a pluripotent stem cell from the niche begins the cascade of steps
towards one or more differentiated cell types [38,39]. Some of
these concepts have been incorporated into the model of cancer
stem cells, or tumor-initiating cells, and their role in tumor
progression and chemotherapeutic resistance [40]. While some
aspects are controversial (such as whether cancer stem cells
originate from normal stem cells, or merely re-express a few stem
cell markers), one of the principal aspects of the model is that these
cells reside in hypoxic regions of tumors and produce rapidly
proliferating cells that migrate to peripheral regions of the tumor
and to distant sites in the body. The methods described in this
report have been developed to provide better data on cell-cell
Table 3. KS statistics of cumulative responses compared in
Figures 5 and 6.
Figure Antigen D kp p
5a WWOX 0.2543 0 0
5b pWWOX 0.1704 0 0
6a c-Jun 0.0495 0.4236 0.4821
6b p73 0.1579 0 0
D: the KS value (maximum difference along the y-axis).
kp: probability that the KS differences seen would be seen by chance alone.
p: t-test for different means.
doi:10.1371/journal.pone.0006822.t003
Figure 6. Distribution of c-Jun and p73 levels in LNCaP cells
cocultured with HUVECs. Cumulative plots of c-Jun (panel A) and
p73 (panel B) in adjacent and non-adjacent LNCaP cells (red and black,
respectively). Data are from single wells, the ratio of c-Jun expression
for the well analyzed in this figure was 0.9952, and that of p73
expression was 0.9155.
doi:10.1371/journal.pone.0006822.g006 Figure 7. Image mosaic analysis of p73 levels in prostate
carcinoma cells. Antigen intensities in LNCaP cells are clustered by
proximity to HUVECs to allow overall comparisons of aggregate
intensity levels between groups. Top: LNCaP cells adjacent to HUVECs;
bottom: LNCaP cells non-adjacent to HUVECs.
doi:10.1371/journal.pone.0006822.g007
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PLoS ONE | www.plosone.org 9 August 2009 | Volume 4 | Issue 8 | e6822interactions for any system where the events can be detected
fluorescently or through morphological changes in one or more
cell type where the cell types can be distinguished, including
systems described above, where the context of the cell is an
important factor in its growth and signaling.
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